相关实验视频

Updated: Sep 13, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

默克尔细胞癌:放射治疗治疗后的长期结果

Enar Recalde Vizcay¹, Begoña Navalpotro Yagüe², Carla Ferrandiz-Pulido³

¹Department of Radiation Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Walk, 119, 08035, Barcelona, Spain. erecaldevizcay@gmail.com.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

|July 31, 2025

概括

默克尔细胞癌 (MCC) 复发是常见的,尽管放射治疗. 早期辅助放射治疗和密切监测至关重要,在早期复发的情况下,有可能加强治疗.

科学领域:

在瘤学瘤学.
辐射瘤学辐射瘤学

背景情况:

默克尔细胞癌 (MCC) 是一种罕见的,具有高死亡率的侵袭性皮肤癌.
关于MCC最佳治疗和复发管理的数据有限.

研究的目的:

为了评估激进和辅助放射治疗对默克尔细胞癌的结果.
为了确定影响MCC患者的复发和生存的因素,用放射治疗治疗.

主要方法:

对17名MCC患者的回顾性分析,这些患者接受了激进和/或辅助放射治疗.
收集关于治疗细节,复发模式,救援疗法和生存结果的数据.

主要成果:

29%的患者在放射治疗后平均5.8个月内复发.
复发主要是局部区域性的;一个患者发生了远程复发.
5名患者 (29%) 死亡,其中大多数死亡是由于活跃的疾病进展.

结论:

尽管进行了最佳的放射治疗,但在MCC中经常出现复发,与预后不佳相关.
建议进行辅助性放射治疗和严格的术后监测.
早期复发可能受益于加强治疗策略.

关键词:

辅助性放射疗法是一种辅助性放射疗法.当地控制局部控制梅克尔细胞癌瘤是什么?神经内分泌癌瘤是一种神经内分泌癌.激进的放射疗法是一种激进的放射疗法.

更多相关视频

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model

Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model

Published on: March 6, 2012

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...